Issuance of Multiple Exemptions in Response to COVID-19 Public Health Emergency, 3851-3852 [2022-01373]

Download as PDF 3851 Federal Register / Vol. 87, No. 16 / Tuesday, January 25, 2022 / Notices Dated: January 11, 2022. For the Nuclear Regulatory Commission. Bo M. Pham, Director, Division of Operating Reactor Licensing, Office of Nuclear Reactor Regulation. [FR Doc. 2022–00765 Filed 1–24–22; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket Nos. 50–341, 50–250, and 50–251; NRC–2020–0110] Issuance of Multiple Exemptions in Response to COVID–19 Public Health Emergency Nuclear Regulatory Commission. ACTION: Exemptions; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) issued two exemptions in response to requests from two licensees for relief due to the coronavirus 2019 disease (COVID–19) public health emergency (PHE). The exemptions afford these licensees temporary relief from certain requirements under NRC regulations. The NRC is issuing a single notice to announce the issuance of the exemptions. DATES: During the period from December 9, 2021, to December 30, 2021, the NRC granted two exemptions in response to requests submitted by two licensees from December 6, 2021, to December 30, 2021. ADDRESSES: Please refer to Docket ID NRC–2020–0110 when contacting the NRC about the availability of information regarding this document. You may obtain publicly available information related to this document using any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2020–0110. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: SUMMARY: Stacy.Schumann@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to PDR.Resource@nrc.gov. For the convenience of the reader, instructions about obtaining materials referenced in this document are provided in the ‘‘Availability of Documents’’ section. • NRC’s PDR: You may examine and purchase copies of public documents, by appointment, at the NRC’s PDR, Room P1 B35, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. To make an appointment to visit the PDR, please send an email to PDR.Resource@nrc.gov or call 1–800–397–4209 or 301–415– 4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal holidays. FOR FURTHER INFORMATION CONTACT: James Danna, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–415–7422, email: James.Danna@nc.gov. SUPPLEMENTARY INFORMATION: The exemptions from certain requirements of 10 CFR part 26 for DTE Electric Company (for Fermi, Unit 2), and Florida Power & Light Company (for Turkey Point Nuclear Generating, Units 3 and 4) afford these licensees temporary relief from the work-hour control requirements under 10 CFR 26.205(d)(1) through (d)(7). The exemptions from 10 CFR 26.205(d)(1) through (d)(7) ensure that the control of work hours and management of worker fatigue does not unduly limit licensee flexibility in using personnel resources to most effectively manage the impacts of the COVID–19 PHE on maintaining the safe operation of these facilities. Specifically, these licensees have stated that their staffing levels are affected or are expected to be affected by the COVID–19 PHE, and they can no longer meet or likely will not meet the workhour controls of 10 CFR 26.205(d)(1) through (d)(7). These licensees have committed to effecting site-specific administrative controls for COVID–19 PHE fatigue-management for personnel specified in 10 CFR 26.4(a). The tables in this notice provide transparency regarding the number and type of exemptions the NRC has issued. Additionally, the NRC publishes tables of approved regulatory actions related to the COVID–19 PHE on its public website at https://www.nrc.gov/aboutnrc/covid-19/reactors/licensingactions.html. I. Introduction During the period from December 9, 2021, to December 30, 2021, the NRC granted two exemptions in response to requests submitted by two licensees from December 6, 2021, to December 30, 2021. These exemptions temporarily allow the licensees to deviate from certain requirements of chapter 1 of title 10 of the Code of Federal Regulations (10 CFR), part 26, ‘‘Fitness for Duty Programs,’’ section 26.205, ‘‘Work hours.’’ The tables in this notice provide the facility name, docket number, document description, and ADAMS accession number for each exemption issued. Additional details on each exemption issued, including the exemption request submitted by the respective licensee and the NRC’s decision, are provided in each exemption approval listed in the tables in this notice. For additional directions on accessing information in ADAMS, see the ADDRESSES section of this document. II. Availability of Documents FERMI, UNIT 2—DOCKET NO. 50–341 khammond on DSKJM1Z7X2PROD with NOTICES Document description ADAMS accession No. Fermi, Unit 2—Work Hour Limits Exemption Request due to COVID–19, dated December 6, 2021 ............................... Fermi, Unit 2—Exemption from Specific Requirements of 10 CFR part 26 (EPID L–2020–LLE–0053 [COVID–19]), dated December 9, 2021 ................................................................................................................................................. ML21340A030 ML21340A245 TURKEY POINT NUCLEAR PLANT, UNITS 3 AND 4—DOCKET NOS. 50–250 AND 50–251 Document description ADAMS accession No. Turkey Point Nuclear Plant, Units 3 and 4—COVID–19 Related Request for Exemption from part 26 Work Hours Requirements, dated December 30, 2021 ........................................................................................................................... VerDate Sep<11>2014 17:19 Jan 24, 2022 Jkt 256001 PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 E:\FR\FM\25JAN1.SGM 25JAN1 ML21364A050 3852 Federal Register / Vol. 87, No. 16 / Tuesday, January 25, 2022 / Notices TURKEY POINT NUCLEAR PLANT, UNITS 3 AND 4—DOCKET NOS. 50–250 AND 50–251—Continued Document description ADAMS accession No. Turkey Point Nuclear Plant Units 3 and 4—Exemption from Specific Requirements of 10 CFR part 26, ‘‘Fitness for Duty Programs’’ (EPID L–2021–LLE–0058 [COVID–19]), dated December 30, 2021 ................................................... Dated: January 20, 2022. For the Nuclear Regulatory Commission. James G. Danna, Chief, Plant Licensing Branch I, Division of Operating Reactor Licensing, Office of Nuclear Reactor Regulation. [FR Doc. 2022–01373 Filed 1–24–22; 8:45 am] BILLING CODE 7590–01–P SECURITIES AND EXCHANGE COMMISSION [Investment Company Act Release No. 34477; File No. 812–15215] MSD Investment, LLC, et al. January 19, 2022. Securities and Exchange Commission (‘‘Commission’’). ACTION: Notice. khammond on DSKJM1Z7X2PROD with NOTICES AGENCY: Notice of application for an order under sections 17(d) and 57(i) of the Investment Company Act of 1940 (the ‘‘Act’’) and rule 17d–1 under the Act to permit certain joint transactions otherwise prohibited by sections 17(d) and 57(a)(4) of the Act and rule 17d–1 under the Act. SUMMARY OF APPLICATION: Applicants request an order to permit certain business development companies (‘‘BDCs’’) and closed-end management investment companies to co-invest in portfolio companies with each other and with certain affiliated investment funds and accounts. APPLICANTS: MSD Investment, Corp., (‘‘Existing Regulated Fund’’), MSD Partners, L.P. (‘‘MSD’’), MSD Credit Opportunity Master Fund, L.P., MSD Credit Opportunity Master Fund II, L.P., MSD Credit Opportunity Fund, L.P., MSD Credit Opportunity Fund (Cayman), L.P., MSD Credit Opportunity Fund, Ltd., MSD Debt REIT Holdings, L.P., MSDC EIV, LLC, MSD EIV Private, LLC, MSD RCOF TRS, LLC, MSD RCOF TRS (Cayman) LTD., MSD Real Estate Credit Opportunity Fund L.P., MSD Real Estate Credit Opportunity Fund-C L.P., RCOF-C Intermediate (Cayman), L.P, RCOF-C Intermediate, L.P., MSD Special Investments Fund, L.P., MSD SIF Holdings, L.P., MSD Special Investments Fund (Cayman), L.P., MSD SIF (Cayman), L.P., MSD Alpine Credit Opportunity Fund, L.P., MSD SBAFLA Fund, L.P., MSD UK Holdings Limited, VerDate Sep<11>2014 17:19 Jan 24, 2022 Jkt 256001 MSD UK Holdings Ltd, MSD UK Aggregator Fund, LLC, MSD PCOF SMA 1, LLC, MSD PCOF SMA 2, LLC, MSD RCOF SMA 1, LLC, MSD RCOF SMA 2, LLC, MSD, Private Credit Opportunity Master (ECI) Fund 2, L.P., MSD Private Credit Opportunity Master Fund 2, L.P., MSD Private Credit Opportunity Fund 2, L.P., MSD Private Credit Opportunity Fund (Cayman) 2, L.P., MSD Private Credit Opportunity Fund (Cayman) II, L.P., Intermediate Fund PCOF 2, LLC, MSD PCOF Fund 2, Ltd, Onshore Intermediate Fund PCOF 2, LLC, MSD Onshore PCOF Fund 2, Ltd, MSD Private Credit Opportunity Master (ECI) Fund, L.P., MSD Private Credit Opportunity Master (ECI) Fund II, L.P., MSD Private Credit Opportunity Master Fund, L.P., MSD Private Credit Opportunity Fund, L.P., MSD Private Credit Opportunity Fund (Cayman), L.P., and MSD Private Credit Opportunity Fund II, L.P. (collectively, ‘‘Existing Affiliated Funds’’). FILING DATES: The application was filed on April 1, 2021, and amended on November 18, 2021 and on January 18, 2022. HEARING OR NOTIFICATION OF HEARING: An order granting the requested relief will be issued unless the Commission orders a hearing. Interested persons may request a hearing by emailing the Commission’s Secretary at SecretarysOffice@sec.gov and serving applicants with a copy of the request by email. Hearing requests should be received by the Commission by 5:30 p.m. on February 10, 2022, and should be accompanied by proof of service on the applicants, in the form of an affidavit, or, for lawyers, a certificate of service. Pursuant to rule 0–5 under the Act, hearing requests should state the nature of the writer’s interest, any facts bearing upon the desirability of a hearing on the matter, the reason for the request, and the issues contested. Persons who wish to be notified of a hearing may request notification by emailing the Commission’s Secretary at SecretarysOffice@sec.gov. ADDRESSES: The Commission: Secretarys-Office@sec.gov. Applicants: Robert Simonds, MSD Partners, L.P., rsimonds@msd.com. FOR FURTHER INFORMATION CONTACT: Harry Eisenstein, Senior Special Counsel, at (202) 551–6764 or Kaitlin C. PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 ML21364A052 Bottock, Branch Chief, at (202) 551– 6825 (Division of Investment Management, Chief Counsel’s Office). SUPPLEMENTARY INFORMATION: The following is a summary of the application. The complete application may be obtained via the Commission’s website by searching for the file number, or for an applicant using the Company name box, at https:// www.sec.gov/search/search.htm or by calling (202) 551–8090. Introduction 1. The applicants request an order of the Commission under sections 17(d) and 57(i) and rule 17d–1 thereunder (the ‘‘Order’’) to permit, subject to the terms and conditions set forth in the application (the ‘‘Conditions’’), a Regulated Fund 1 and one or more other Regulated Funds and/or one or more Affiliated Funds 2 to enter into CoInvestment Transactions with each other. ‘‘Co-Investment Transaction’’ means any transaction in which a 1 ‘‘Regulated Funds’’ means the Existing Regulated Fund, the Future Regulated Funds and the BDC Downstream Funds (defined below). ‘‘Future Regulated Fund’’ means a closed-end management investment company (a) that is registered under the Act or has elected to be regulated as a BDC, (b) whose investment adviser (and sub-adviser(s), if any) are an Adviser, and (c) that intends to participate in the Co-investment Program. ‘‘Adviser’’ means MSD and any Future Adviser. ‘‘Future Adviser’’ means any future investment adviser that (i) controls, is controlled by, or is under common control with MSD, (ii) (a) is registered as an investment adviser under the Investment Advisers Act of 1940 (‘‘Advisers Act’’) or (b) is a relying adviser of an investment adviser that is registered under the Advisers Act, and that controls, is controlled by, or is under common control with, MSD, and (iii) is not a Regulated Fund or a subsidiary of a Regulated Fund. 2 ‘‘Affiliated Fund’’ means any Existing Affiliated Fund, any MSD Proprietary Account (as defined below) and any entity (a) whose investment adviser (and sub-adviser(s), if any) are Advisers, (b) that either (i) would be an investment company but for section 3(c)(1), 3(c)(5)(C) or 3(c)(7) of the Act or (ii) relies on rule 3a–7 under the Act, (c) that is not a BDC Downstream Fund, and (d) that intends to participate in the Co-Investment Program. ‘‘BDC Downstream Fund’’ means, with respect to any Regulated Fund that is a business development company (‘‘BDC’’), an entity (i) that the BDC directly or indirectly controls, (ii) that is not controlled by any person other than the BDC (except a person that indirectly controls the entity solely because it controls the BDC), (iii) that would be an investment company but for section 3(c)(1) or 3(c)(7) of the Act, (iv) whose investment adviser (and sub-adviser(s), if any) are an Adviser, (v) that is not a Wholly-Owned Investment Sub and (vi) that intends to participate in the Co-Investment Program (defined below). E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 87, Number 16 (Tuesday, January 25, 2022)]
[Notices]
[Pages 3851-3852]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01373]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket Nos. 50-341, 50-250, and 50-251; NRC-2020-0110]


Issuance of Multiple Exemptions in Response to COVID-19 Public 
Health Emergency

AGENCY: Nuclear Regulatory Commission.

ACTION: Exemptions; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) issued two 
exemptions in response to requests from two licensees for relief due to 
the coronavirus 2019 disease (COVID-19) public health emergency (PHE). 
The exemptions afford these licensees temporary relief from certain 
requirements under NRC regulations. The NRC is issuing a single notice 
to announce the issuance of the exemptions.

DATES: During the period from December 9, 2021, to December 30, 2021, 
the NRC granted two exemptions in response to requests submitted by two 
licensees from December 6, 2021, to December 30, 2021.

ADDRESSES: Please refer to Docket ID NRC-2020-0110 when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly available information related to this document 
using any of the following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2020-0110. Address 
questions about Docket IDs in Regulations.gov to Stacy Schumann; 
telephone: 301-415-0624; email: [email protected]. For technical 
questions, contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to [email protected]. For the convenience of the reader, 
instructions about obtaining materials referenced in this document are 
provided in the ``Availability of Documents'' section.
     NRC's PDR: You may examine and purchase copies of public 
documents, by appointment, at the NRC's PDR, Room P1 B35, One White 
Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. To make 
an appointment to visit the PDR, please send an email to 
[email protected] or call 1-800-397-4209 or 301-415-4737, between 
8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal 
holidays.

FOR FURTHER INFORMATION CONTACT: James Danna, Office of Nuclear Reactor 
Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001; telephone: 301-415-7422, email: [email protected].

SUPPLEMENTARY INFORMATION:

I. Introduction

    During the period from December 9, 2021, to December 30, 2021, the 
NRC granted two exemptions in response to requests submitted by two 
licensees from December 6, 2021, to December 30, 2021. These exemptions 
temporarily allow the licensees to deviate from certain requirements of 
chapter 1 of title 10 of the Code of Federal Regulations (10 CFR), part 
26, ``Fitness for Duty Programs,'' section 26.205, ``Work hours.''
    The exemptions from certain requirements of 10 CFR part 26 for DTE 
Electric Company (for Fermi, Unit 2), and Florida Power & Light Company 
(for Turkey Point Nuclear Generating, Units 3 and 4) afford these 
licensees temporary relief from the work-hour control requirements 
under 10 CFR 26.205(d)(1) through (d)(7). The exemptions from 10 CFR 
26.205(d)(1) through (d)(7) ensure that the control of work hours and 
management of worker fatigue does not unduly limit licensee flexibility 
in using personnel resources to most effectively manage the impacts of 
the COVID-19 PHE on maintaining the safe operation of these facilities. 
Specifically, these licensees have stated that their staffing levels 
are affected or are expected to be affected by the COVID-19 PHE, and 
they can no longer meet or likely will not meet the work-hour controls 
of 10 CFR 26.205(d)(1) through (d)(7). These licensees have committed 
to effecting site-specific administrative controls for COVID-19 PHE 
fatigue-management for personnel specified in 10 CFR 26.4(a).
    The tables in this notice provide transparency regarding the number 
and type of exemptions the NRC has issued. Additionally, the NRC 
publishes tables of approved regulatory actions related to the COVID-19 
PHE on its public website at https://www.nrc.gov/about-nrc/covid-19/reactors/licensing-actions.html.

II. Availability of Documents

    The tables in this notice provide the facility name, docket number, 
document description, and ADAMS accession number for each exemption 
issued. Additional details on each exemption issued, including the 
exemption request submitted by the respective licensee and the NRC's 
decision, are provided in each exemption approval listed in the tables 
in this notice. For additional directions on accessing information in 
ADAMS, see the ADDRESSES section of this document.

                    Fermi, Unit 2--Docket No. 50-341
------------------------------------------------------------------------
              Document description                 ADAMS accession No.
------------------------------------------------------------------------
Fermi, Unit 2--Work Hour Limits Exemption                    ML21340A030
 Request due to COVID-19, dated December 6,
 2021..........................................
Fermi, Unit 2--Exemption from Specific                       ML21340A245
 Requirements of 10 CFR part 26 (EPID L-2020-
 LLE-0053 [COVID-19]), dated December 9, 2021..
------------------------------------------------------------------------


Turkey Point Nuclear Plant, Units 3 and 4--Docket Nos. 50-250 and 50-251
------------------------------------------------------------------------
              Document description                 ADAMS accession No.
------------------------------------------------------------------------
Turkey Point Nuclear Plant, Units 3 and 4--                  ML21364A050
 COVID-19 Related Request for Exemption from
 part 26 Work Hours Requirements, dated
 December 30, 2021.............................

[[Page 3852]]

 
Turkey Point Nuclear Plant Units 3 and 4--                   ML21364A052
 Exemption from Specific Requirements of 10 CFR
 part 26, ``Fitness for Duty Programs'' (EPID L-
 2021-LLE-0058 [COVID-19]), dated December 30,
 2021..........................................
------------------------------------------------------------------------


    Dated: January 20, 2022.

    For the Nuclear Regulatory Commission.
James G. Danna,
Chief, Plant Licensing Branch I, Division of Operating Reactor 
Licensing, Office of Nuclear Reactor Regulation.
[FR Doc. 2022-01373 Filed 1-24-22; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.